NSB Advisors’s Bristol-Myers Squibb BMY Stock Holding History

NSB Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,426	Closed	-$221K	–	1
2015 Q1	$221K	Hold	3,426	–	–	0.28%	25
2014 Q4	$202K	Buy	+3,426	New	+$193K	0.2%	27

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NSB Advisors's BMY Position: Q2 2015 in Review

NSB Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2015, closing a stake of 3,426 shares — an estimated $221K sold.

NSB Advisors first reported a position in BMY in Q4 2014 and held it in 2 quarters. The position peaked at $221K in Q1 2015. 1,447 funds tracked by Wall St. Rank hold BMY as of Q2 2015.

NSB Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2015 after selling out during the quarter.
NSB Advisors sold 3,426 Bristol-Myers Squibb shares in Q2 2015, an estimated $221K.
NSB Advisors first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 2 quarters.
NSB Advisors's Bristol-Myers Squibb position peaked at $221K in Q1 2015.
1,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.

Based on NSB Advisors's 13F filing for Q2 2015.